- Top
- Abount us
Abount us
Member
Katsuhisa HORIMOTO, Ph.D.
Board Director CEO, Founder
Tokyo Univ. of Science, Ph.D.(Biophysics),The Univ. of Tokyo, AIST
>130 peer-reviewed papers on computational systems biology, 8 parents of algorithms.
2017/9 Co-founder of SOCIUM.
2019/4 Visiting Professor of Saitama Medical Univ.
>130 peer-reviewed papers on computational systems biology, 8 parents of algorithms.
2017/9 Co-founder of SOCIUM.
2019/4 Visiting Professor of Saitama Medical Univ.
Michio SHIGEMORI, MBA
Board Director, CFO
Meiji Univ., MBA
Worked in global treasury services at Bank of America and treasury operations at BASF Metals Japan.
2022/6 Joined SOCIUM
2024/1 Board Director CFO
Worked in global treasury services at Bank of America and treasury operations at BASF Metals Japan.
2022/6 Joined SOCIUM
2024/1 Board Director CFO
Tadashi HORIUCHI, Ph.D.
Outside Director
Worked in Daiichi Pharmaceutical Co., Ltd (currently Daiichi Sankyo Co., Ltd.) and Asubio Pharma Co., Ltd. (currently Daiichi Sankyo Co., Ltd.).
2008/4 Senior Coodinator of Center for Research Promotion, Comprehensive Research Promotion Organization, Keio University
2016/4 Guest Professor of Clinical & Translational Research Center, Keio University Hospital
2017/9 Science and Technical Advisor, Japan Agency for Medical Research and Development
2024/7 joined SOCIUM
2008/4 Senior Coodinator of Center for Research Promotion, Comprehensive Research Promotion Organization, Keio University
2016/4 Guest Professor of Clinical & Translational Research Center, Keio University Hospital
2017/9 Science and Technical Advisor, Japan Agency for Medical Research and Development
2024/7 joined SOCIUM
Makoto MIURA
Audit & Supervisory Board Member
Graduated from the Univ. of Tokyo, Faculty of Economics.
Worked in U.S. GAAP auditing of megabanks at Deloitte Touche Tohmatsu LLC and Established Makoto Miura CPA Office.
2018/10 Joined SOCIUM
Worked in U.S. GAAP auditing of megabanks at Deloitte Touche Tohmatsu LLC and Established Makoto Miura CPA Office.
2018/10 Joined SOCIUM
Company Profile
Segments |
① Drug repositioning platform based on a combination of proprietary technologies, and the world’s first phosphorylation analysis technology
|
Foundation date | Sep. 2017 |
CEO | Katsuhisa Horimoto |
Office | 17-1, Nihonbashi-Kabuto-cho, Chuo-ku, Tokyo 103-0026, Japan |
Laboratory | AIST Tokyo Waterfront, 2-4-7, Aomi, Koto-ku, Tokyo 135-0064, Japan |
Career
Click here for Career Information